AB
GBIO

Amalgamated Bank’s Generation Bio GBIO Stock Holding History

Amalgamated Bank’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-153
Closed -$1K – 3054
2025
Q1 		$1K Hold
153
– – ﹤0.01% 2909
2024
Q4 		$2K Hold
153
– – ﹤0.01% 2899
2024
Q3 		$4K Hold
153
– – ﹤0.01% 2813
2024
Q2 		$4K Hold
153
– – ﹤0.01% 2847
2024
Q1 		$6K Sell
153
-242
-61% -$5.7K ﹤0.01% 2637
2023
Q4 		$7K Sell
395
-45
-10% -$785 ﹤0.01% 2910
2023
Q3 		$17K Hold
440
– – ﹤0.01% 2726
2023
Q2 		$24K Sell
440
-39
-8% -$1.79K ﹤0.01% 2647
2023
Q1 		$21K Sell
479
-117
-20% -$5.66K ﹤0.01% 2623
2022
Q4 		$23K Hold
596
– – ﹤0.01% 2714
2022
Q3 		$32K Buy
596
+18
+3% +$1.13K ﹤0.01% 2647
2022
Q2 		$38K Sell
578
-126
-18% -$8.24K ﹤0.01% 2610
2022
Q1 		$52K Buy
+704
New +$40.8K ﹤0.01% 2461
2021
Q3 		– Sell
-814
Closed -$219K – 2171
2021
Q2 		$219K Buy
+814
New +$243K ﹤0.01% 2001

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's GBIO Position: Q2 2025 in Review

Amalgamated Bank sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 153 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in GBIO in Q2 2021 and held it in 14 quarters. The position peaked at $219K in Q2 2021. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Amalgamated Bank reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 153 Generation Bio shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Generation Bio in Q2 2021 and held it in 14 quarters.
  • Amalgamated Bank's Generation Bio position peaked at $219K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.